Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease.

Plazzo AP, Filz V, Prothiwa M, Lambrecht R, Delgado ME, Fleming JR, Duschek J, Pilgram E, Friedrich J, Eisenring R, Kurtz L, Stemmer K, Stenman LK, Amaya Garcia F, Unterlass M, Mayans O, Böttcher T, Brunner T

Open source

DOI
10.1038/s44321-026-00516-3
Published
2026 Sep 17
Container
EMBO molecular medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44321-026-00516-3,
  title = {Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease.},
  author = {Plazzo AP and Filz V and Prothiwa M and Lambrecht R and Delgado ME and Fleming JR and Duschek J and Pilgram E and Friedrich J and Eisenring R and Kurtz L and Stemmer K and Stenman LK and Amaya Garcia F and Unterlass M and Mayans O and Böttcher T and Brunner T},
  year = {2026},
  journal = {EMBO molecular medicine},
  doi = {10.1038/s44321-026-00516-3},
  url = {https://doi.org/10.1038/s44321-026-00516-3}
}

RIS

TY  - JOUR
TI  - Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease.
AU  - Plazzo AP
AU  - Filz V
AU  - Prothiwa M
AU  - Lambrecht R
AU  - Delgado ME
AU  - Fleming JR
AU  - Duschek J
AU  - Pilgram E
AU  - Friedrich J
AU  - Eisenring R
AU  - Kurtz L
AU  - Stemmer K
AU  - Stenman LK
AU  - Amaya Garcia F
AU  - Unterlass M
AU  - Mayans O
AU  - Böttcher T
AU  - Brunner T
PY  - 2026
JO  - EMBO molecular medicine
DO  - 10.1038/s44321-026-00516-3
UR  - https://doi.org/10.1038/s44321-026-00516-3
ER  - 

APA

AP, P., V, F., M, P., R, L., ME, D., JR, F., J, D., E, P., J, F., R, E., L, K., K, S., LK, S., F, A. G., M, U., O, M., T, B., & T, B. (2026). Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease.. EMBO molecular medicine. https://doi.org/10.1038/s44321-026-00516-3

Source records